NEWGEN · NSE Technology Large Cap

Newgen Software Technologies Limited

NEWGEN  ·  National Stock Exchange of India

NEWGEN is currently trading at ₹506, 5.1% above its 50-day moving average. The Kasauti methodology audit finds 1 of 8 structural parameters confirmed, placing this instrument in the Does Not Pass Yet category.

Data Execution Timestamp: 24 July 2026 · NSE Closing Bell
Overall Verdict
अभी नहीं मित्र
Does Not Pass Yet
Minervini SEPA 1 / 8
Weinstein Stage Stage 4 — Decline
Base Advance Top Decline
52-Week Price History — Weekly
₹506 Snapshot · NSE Closing Bell · 24 Jul 2026
₹396 ₹602 ₹808 ₹1.0k ₹1.2k Jul '25 Oct '25 Jan '26 Apr '26 Jul '26 52W H ₹1.0k
Weekly close 50 DMA 200 DMA 52W high

Minervini SEPA — 8 Parameter Audit

Parameter Result Data
Price above 150 & 200 DMA
Minervini SEPA · Criterion 1
FAIL Price ₹506 · 150 DMA ₹534 · 200 DMA ₹624
150 DMA above 200 DMA
Minervini SEPA · Criterion 2
FAIL 150 DMA ₹534 vs 200 DMA ₹624 (-14.3%)
200 DMA trending up ≥ 1 month
Minervini SEPA · Criterion 3
FAIL 200 DMA slope: -5.64% over 4 weeks
50 DMA above 150 & 200 DMA
Minervini SEPA · Criterion 4
FAIL 50 DMA ₹481 · 150 DMA ₹534 · 200 DMA ₹624
Price above 50 DMA
Minervini SEPA · Criterion 5
PASS Price ₹506 · 50 DMA ₹481 (+5.1%)
Price within 25% of 52-week high
Minervini SEPA · Criterion 6
FAIL ₹506 vs 52W high ₹1,030 (-50.9%)
Price ≥ 30% above 52-week low
Minervini SEPA · Criterion 7
FAIL ₹506 vs 52W low ₹397 (+27.5%)
RS Rating ≥ 70
Minervini SEPA · Criterion 8
FAIL RS Rating: 16 (threshold: ≥70)

Weinstein Stage Analysis

Stage 1
Base
Stage 2
Advance
Stage 3
Top
Stage 4
Decline

NEWGEN.NS is in Weinstein Stage 4 — the declining phase. Price is below all key moving averages, the 200 DMA is trending downward, and the structure reflects distribution. Position traders applying strict methodology have no participation during Stage 4.

Relative Strength Rating

16 Stronger than 16% of the NSE universe
↑ Improving over 13 weeks

Structural Analysis

Newgen Software Technologies Limited is currently trading 5.1% above its 50-day moving average, with Weinstein Stage 4 confirmed by the moving average hierarchy.

The Minervini SEPA audit finds 1 of 8 parameters confirmed. The parameter(s) not confirmed: Price above 150 & 200 DMA, 150 DMA above 200 DMA, 200 DMA trending up, 50 DMA above 150 & 200 DMA, Within 25% of 52W high, 30% above 52W low, RS Rating ≥70.

Sanjaya's Reading

The Witness Speaks

Mitra, main dekh raha hoon Newgen Software Technologies Limited ko — 1 criteria poore hain aath mein se.

Weinstein Stage 4 mein hai yeh instrument. अभी नहीं मित्र.

This is a static snapshot

This audit was generated from NSE closing data on 24 July 2026. Run a live audit with real-time data, animated criteria reveals, and Sanjaya's full narration.

Run a Live Audit — Free →

Free tier includes Nifty 50 stocks · Pro unlocks full NSE universe

Frequently Asked Questions

Does NEWGEN pass the Minervini SEPA criteria?

NEWGEN (Newgen Software Technologies Limited) currently meets 1 of 8 Minervini SEPA parameters. NEWGEN currently meets 1 of 8 Minervini SEPA parameters. The parameter(s) not confirmed: Price above 150 & 200 DMA, 150 DMA above 200 DMA, 200 DMA trending up, 50 DMA above 150 & 200 DMA, Within 25% of 52W high, 30% above 52W low, RS Rating ≥70.

What is the Weinstein Stage Analysis for NEWGEN?

NEWGEN is currently in Weinstein Stage 4. NEWGEN.NS is in Weinstein Stage 4 — the declining phase. Price is below all key moving averages, the 200 DMA is trending downward, and the structure reflects distribution. Position traders applying strict methodology have no participation during Stage 4.

Is NEWGEN structurally aligned for position trading?

The Kasauti verdict for NEWGEN is अभी नहीं मित्र (Does Not Pass Yet). The Kasauti verdict for NEWGEN.NS is अभी नहीं मित्र — Does Not Pass Yet. With 1 of 8 criteria met, the primary area to monitor is: Price above 150 & 200 DMA, 150 DMA above 200 DMA, 200 DMA trending up, 50 DMA above 150 & 200 DMA, Within 25% of 52W high, 30% above 52W low, RS Rating ≥70. This is a structural methodology assessment only — not a recommendation to deploy or exit capital. This is a structural methodology assessment only — not a recommendation to deploy or exit capital.

Methodology Assessment Disclaimer: This page presents a systematic structural audit of NEWGEN against methodology parameters derived from the published works of Mark Minervini and Stan Weinstein. All data is sourced from NSE end-of-day prices. This content is for educational and analytical purposes only. Kasauti™ does not provide investment advice, stock recommendations, or capital deployment directives. Always conduct independent research and consult a SEBI-registered investment adviser before making any financial decisions.